Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

An innovative new study from researchers at the Center for Healthy Brain Aging (CHeBA), UNSW Sydney, reveals that something as simple as a mouse's dinner could be distorting critical preclinical ...

Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation ("VoxCell"), a leader in 3D ...

Eton Pharmaceuticals (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.